XML 80 R55.htm IDEA: XBRL DOCUMENT v3.24.0.1
Revenue Recognition - Schedule of Revenue by Product (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Disaggregation of Revenue [Line Items]      
Revenue $ 4,655.6 $ 4,451.6 $ 4,138.7
CSCA      
Disaggregation of Revenue [Line Items]      
Revenue 2,962.3 2,925.9 2,693.1
CSCA | Nutrition      
Disaggregation of Revenue [Line Items]      
Revenue 563.2 520.4 401.9
CSCA | Upper Respiratory      
Disaggregation of Revenue [Line Items]      
Revenue 559.2 564.6 483.1
CSCA | Digestive Health      
Disaggregation of Revenue [Line Items]      
Revenue 505.3 495.5 475.1
CSCA | Pain and Sleep-Aids      
Disaggregation of Revenue [Line Items]      
Revenue 396.4 412.2 405.4
CSCA | Oral Care      
Disaggregation of Revenue [Line Items]      
Revenue 313.9 312.9 311.9
CSCA | Healthy Lifestyle      
Disaggregation of Revenue [Line Items]      
Revenue 311.7 288.9 295.0
CSCA | Skin Care      
Disaggregation of Revenue [Line Items]      
Revenue 196.2 187.8 183.7
CSCA | Women's Health      
Disaggregation of Revenue [Line Items]      
Revenue 46.9 45.2 38.2
CSCA | Vitamins, Minerals, and Supplements ("VMS")      
Disaggregation of Revenue [Line Items]      
Revenue 17.5 27.9 31.7
CSCA | Other CSCA      
Disaggregation of Revenue [Line Items]      
Revenue 52.0 70.5 67.1
CSCI      
Disaggregation of Revenue [Line Items]      
Revenue 1,693.3 1,525.7 1,445.6
CSCI | Upper Respiratory      
Disaggregation of Revenue [Line Items]      
Revenue 299.1 268.7 219.4
CSCI | Digestive Health      
Disaggregation of Revenue [Line Items]      
Revenue 41.0 35.5 25.6
CSCI | Pain and Sleep-Aids      
Disaggregation of Revenue [Line Items]      
Revenue 222.9 200.2 184.8
CSCI | Oral Care      
Disaggregation of Revenue [Line Items]      
Revenue 101.5 94.8 94.0
CSCI | Healthy Lifestyle      
Disaggregation of Revenue [Line Items]      
Revenue 225.7 209.7 227.6
CSCI | Skin Care      
Disaggregation of Revenue [Line Items]      
Revenue 372.5 334.6 324.0
CSCI | Women's Health      
Disaggregation of Revenue [Line Items]      
Revenue 119.7 96.1 54.5
CSCI | Vitamins, Minerals, and Supplements ("VMS")      
Disaggregation of Revenue [Line Items]      
Revenue 185.5 183.9 225.8
CSCI | Other CSCI      
Disaggregation of Revenue [Line Items]      
Revenue $ 125.4 $ 102.2 $ 89.9